ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVCT Avacta Group Plc

43.25
-0.25 (-0.57%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -0.57% 43.25 42.50 44.00 43.50 42.50 43.50 1,514,338 16:23:43
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.13 122.66M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 43.50p. Over the last year, Avacta shares have traded in a share price range of 42.50p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £122.66 million. Avacta has a price to earnings ratio (PE ratio) of -3.13.

Avacta Share Discussion Threads

Showing 79776 to 79797 of 79875 messages
Chat Pages: 3195  3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  Older
DateSubjectAuthorDiscuss
27/4/2024
15:51
Very rare for Big Pharma to come in at this stage

Although there are some examples

2 week testing may be a catalyst

sandcrab2
27/4/2024
15:22
Down here nobody cares about conviboys, MM games, longs or shorts. This is why the thread is so quiet despite an 8% rise yesterday.

What investors want to see is evidence the drug actually works. People who don't know or think they know what's going on blame the falling share price on the death spiral. I've said it before and I'll say it again AVCT does not have death spiral financing and even if it did it is not the reason why the share price has dropped from 180p in February last year to 48p today.

The problem for AVCT is that the commercial pharmacology industry has seen no evidence to date that suggests AVA6000 is an improvement on Dox on its own. The data presented so far is not independent and there is no peer review in any medical journals to confirm even partial efficacy of AVA6000.

As result of this AVCT cannot source the $billions of dollars normally available for early stage cancer drugs that show promising potential. This is why it had to tap the AIM mug punter market at 50p and not 500p.

I have opined countless times before and will say so again AVA6000 is as bogus as the world beating LFT and it does please me that many of my earlier and later critics are beginning to see that I was right all along.

pwhite73
26/4/2024
16:32
Shorts closing ...conviboys and linked mm games. Ride it baby, ride it...
amanitaangelicus
25/4/2024
12:17
Whitey ...pmsl! Sooo funny.
amanitaangelicus
24/4/2024
23:16
Aman - "Ps Whitey, have you worked out what shipping is? How about patents?"

I'm still working on both as no LFT was ever shipped and no patents were ever granted.

pwhite73
24/4/2024
20:29
Apparently not.
jonc
24/4/2024
17:49
Amanitaangelicus24 Apr '24 - 16:44 - 57586 of 57587
0 0 0
Green eyed monsters on the loose..
-----
WoT uTTer shYTe ... highOn pish

andymunchkin
24/4/2024
17:05
Everything is rigged .......
jimarilo101
24/4/2024
13:45
Aman - "Bouncing off support. Stick with me ..."

The stock is blue today so your 43p collapse prediction is now a support level and shareholders should stick with you. How can they stick with you when nobody knows or has ever known where you are until you announce your winning trade.

Fortunately for shareholders on this thread there is someone who knows exactly where you are or more to the point where you aren't and that's me.

pwhite73
24/4/2024
13:40
bones698 - "The market doesn't like loss making biotechs atm"

It's not the loss making its the having a product the professional biotech industry considers is of no pharmacological worth that is the issue here.

A £125 million market cap for a loss making biotech with potential new cancer drugs in the pipeline is peanuts. Big Pharmas snap these up with money down the back of the sofa.

pwhite73
24/4/2024
13:03
Bouncing off support. Stick with me ...
amanitaangelicus
24/4/2024
10:41
43p lower tbh. I suspect it will come to ur to drift lower without news. Mkt cap still very high for such a company and with a lot of hurdles still to go. They aren't cash rich so that will keep the share price under pressure imo

Mkt cap 125m and some way from breaking even which will keep requiring cash tonpkug the gap. The market doesn't like loss making biotechs atm and that is what this is for now. The future may bbegood but getting there is a long and painful road.

bones698
24/4/2024
09:27
Just how low can this now go ?
2000max
23/4/2024
17:24
Munchmeolfruitcakeuokbuddy?canugivewhiteysomeadvicebitte?Hellneedtoknowhowtogwtadmittedtohospitalforhislongplannedlobotomy.Latersnumbusnutuscenturion.
amanitaangelicus
23/4/2024
13:44
JakNife23 Apr '24 - 12:35 - 57577 of 57579
0 1 1
PWhite73,

"Now had you predicted 43p when this was 180p in February last year that would be something to pat yourself on the back about."

You have to admit that my prediction on the stage at ShareStock last year (23 Sept) that the placing would be at 50p (the share price then was 129p) was pretty impressive!

JakNife
-----
smOOthERed thEm with a STanlEY kNifE!!! letsCall IT a jakStroke

andymunchkin
23/4/2024
13:42
PWhite7323 Apr '24 - 11:53 - 57576 of 57579
0 8 0
Aman - "Peeps laughed my 43p prediction"

When a placing is announced at 50p, 43p two days later is hardly a prediction is it?

Now had you predicted 43p when this was 180p in February last year that would be something to pat yourself on the back about.
----
tis lOwlIfe p&d merChaant aka amaniLicious is alwaYs paTTing him?herself

andymunchkin
23/4/2024
12:35
PWhite73,

"Now had you predicted 43p when this was 180p in February last year that would be something to pat yourself on the back about."

You have to admit that my prediction on the stage at ShareStock last year (23 Sept) that the placing would be at 50p (the share price then was 129p) was pretty impressive!

JakNife

jaknife
23/4/2024
11:53
Aman - "Peeps laughed my 43p prediction"

When a placing is announced at 50p, 43p two days later is hardly a prediction is it?

Now had you predicted 43p when this was 180p in February last year that would be something to pat yourself on the back about.

And by the way who was laughing?

pwhite73
23/4/2024
11:00
Peeps laughed my 43p prediction ...obvious support level ...unlikely to hold though unless stellar news inbound. Hey ho. GL sufferers. Simon andcGarfunkel ...Slip sliding away ...singalong.
amanitaangelicus
23/4/2024
08:58
Results on the 30th April.

Will all be revealed ?

I would very much hope that within two years the trials will have given results that either make or break the company. (make i must add)

Seven more dilutions (next 24 months) or sale of the DX !!! What will it be ?

fieldhouse
23/4/2024
08:42
So, another 3.5 years to pay off the debt, if they last that long..!
filthypoor
23/4/2024
08:16
Remember though, if this works in Phase 2 as well as Smith says so, it s a game changer and the company will be valued way, way higher than today - fact. While to go til we get there tho. Cat n mouse over the next 1-2 years. Dilution v potential game changer. It s still a moral, noble cause- we need this tech to work for all of our sakes. Need more data. Simples. GLA genuine posters.
amanitaangelicus
Chat Pages: 3195  3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  Older